Search

everythinglearnresearchcommunity

for

Search:↓

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

Patients with alopecia areata might have a lower risk of stroke and possibly heart attack.

BD 1/4 dilution is the best for treating localized alopecia areata in adults.

Platelet-Rich Plasma treatment helps hair regrowth in people with mild Alopecia Areata, improving their quality of life with minimal side effects.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Alopecia areata patients have a higher risk of blood clots.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.

Topical clobetasol propionate 0.05% ointment is more effective in promoting hair regrowth in patients with alopecia areata than topical tacrolimus 0.1% ointment.

People with alopecia areata had lower vitamin D levels, but these levels did not relate to how severe their condition was.

Women with alopecia often experience high levels of anxiety and depression, needing psychiatric help.

Topical calcipotriol may help treat alopecia areata, especially in those with low vitamin D.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

Early high-dose steroid treatment helps prolong disease-free periods in severe alopecia areata.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Yellow dots are common in severe alopecia areata.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

JAK inhibitors offer new hope for treating severe alopecia areata.